TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 321094

Group type: EXPERIMENTAL
Intervention: Low-dose oxytetracycline (250 mg twice a day)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Triple tetracycline
Number of subjects: 400

Group type: COMPARATOR
Intervention: Sustained-release tetracycline hydrochloride
Number of subjects: 400

Group type: COMPARATOR
Intervention: Empirical treatment of asymptomatic contacts
Number of subjects: 400
Study: 31149991

Group type: EXPERIMENTAL
Intervention: NanoMed
Number of subjects: 520

Group type: COMPARATOR
Intervention: Orsiro
Number of subjects: 520
Study: 28438152

Group type: EXPERIMENTAL
Intervention: Intervention group A (trained and delivered the intervention at baseline)
Number of subjects: 1263

Group type: EXPERIMENTAL
Intervention: Intervention group B (training and delivery 3 months later)
Number of subjects: 1263

Group type: EXPERIMENTAL
Intervention: Intervention (community pharmacist-led Medicines Use Review)
Number of subjects: 1263
Study: 25747997

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (RT)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Resistance training with protein and vitamin supplementation (RTS)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Cognitive training (CT)
Number of subjects: 97
Study: 22741052

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg orally, given 6 hours before and 6 to 12 hours after surgery
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (control group), given 6 hours before and 6 to 12 hours after surgery
Number of subjects: 80
Study: 19399753

Group type: EXPERIMENTAL
Intervention: New intervention (not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Value of information methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation strategies (not specified)
Number of subjects: 0
Study: 18483353

Group type: COMPARATOR
Intervention: Attention control intervention of standardized materials in the public domain
Number of subjects: 543
Study: 16418586

Group type: EXPERIMENTAL
Intervention: Versed + Fentanyl
Number of subjects: 100

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 100
Study: 12790360

Group type: EXPERIMENTAL
Intervention: Takotsubo cardiomyopathy
Number of subjects: 26

Group type: COMPARATOR
Intervention: ACS
Number of subjects: 26
Study: 10228254

Group type: EXPERIMENTAL
Intervention: Flumazenil (0.1 mg/mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 60
Study: 8734180

Group type: EXPERIMENTAL
Intervention: Ticlopidine 0.25 g/day and aspirin 0.10 g/day for one month with low molecular weight heparin
Number of subjects: 1294

Group type: EXPERIMENTAL
Intervention: Low incidence of subocclusion after coronary stenting
Number of subjects: 1294
Study: 1915909

Group type: EXPERIMENTAL
Intervention: HUV
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: PTFE
Number of subjects: 191
Study: 6343750

Group type: EXPERIMENTAL
Intervention: Combination therapy (preoperative gamma-therapy with doses of 4-5 Gy up to 20-25 Gy or 10 Gy up to 50 Gy)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Surgical treatment alone
Number of subjects: 154
Study: 30240024

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1 mL intra-articular injection)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Saline (1 mL intra-articular injection)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 54
Study: 29161530

Group type: EXPERIMENTAL
Intervention: Family-centered breastfeeding education program (two prenatal lectures, three home visits, eight telephone calls, text/video/audio support, quality online resources)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Family-centered breastfeeding education program
Number of subjects: 59

Group type: COMPARATOR
Intervention: In-hospital care and follow-up by community nurses
Number of subjects: 59
Study: 27693898

Group type: EXPERIMENTAL
Intervention: Fentanyl Buccal Tablet (FBT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Immediate-release morphine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fentanyl Buccal Tablet (FBT) and Immediate-release morphine
Number of subjects: 10
Study: 23594026

Group type: EXPERIMENTAL
Intervention: Sandwich bone augmentation with a bovine pericardium membrane
Number of subjects: 26

Group type: COMPARATOR
Intervention: No membrane (control group)
Number of subjects: 26
Study: 22222005

Group type: EXPERIMENTAL
Intervention: EPO therapy (5,000 IU subcutaneously at 48 h and 72 h after IS)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: hs‐CRP levels at 48 h and day 21 after IS
Number of subjects: 160
Study: 19559369

Group type: EXPERIMENTAL
Intervention: Intraoperative navigation
Number of subjects: 20

Group type: COMPARATOR
Intervention: No intraoperative navigation (Control)
Number of subjects: 20
Study: 17727352

Group type: EXPERIMENTAL
Intervention: Newly developed diary assessing number of satisfactory sexual events (SSEs) per week
Number of subjects: 865

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 865
Study: 16407341

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quinine-doxycycline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 0
Study: 14998223

Group type: EXPERIMENTAL
Intervention: Red blood cell transfusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erythropoietic agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood-conservation tools and minimization of phlebotomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Investigational oxygen-carrying agents
Number of subjects: 0
Study: 11035671

Group type: EXPERIMENTAL
Intervention: Auto-CPAP (pressure range 6 to 16 cm H(2)O)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Constant CPAP
Number of subjects: 25
Study: 8832540

Group type: EXPERIMENTAL
Intervention: Training group
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 15
Study: 1575180

Group type: EXPERIMENTAL
Intervention: Psychological stress monitoring and intervention (home nursing visits for high stress symptoms)
Number of subjects: 461

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 461
Study: 4049902

Group type: EXPERIMENTAL
Intervention: 1 mg loprazolam
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 2 mg loprazolam
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31852704

Group type: EXPERIMENTAL
Intervention: Manualised package of interventions for TB treatment adherence
Number of subjects: 0
Study: 28720615

Group type: EXPERIMENTAL
Intervention: Ethosuximide
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study: 25963890

Group type: EXPERIMENTAL
Intervention: LDV/SOF with RBV
Number of subjects: 1952

Group type: COMPARATOR
Intervention: LDV/SOF without RBV
Number of subjects: 1952
Study: 23565760

Group type: EXPERIMENTAL
Intervention: Linagliptin (5 mg once daily)
Number of subjects: 618

Group type: COMPARATOR
Intervention: Metformin (up to 2250 mg/day)
Number of subjects: 618
Study: 21342151

Group type: EXPERIMENTAL
Intervention: Thiopental 2.5 mg/kg
Number of subjects: 78

Group type: COMPARATOR
Intervention: Propofol 1.0 mg/kg
Number of subjects: 78
Study: 20467604

Group type: EXPERIMENTAL
Intervention: 2 g amoxicillin orally 1 hour before implant placement
Number of subjects: 105

Group type: COMPARATOR
Intervention: Identical placebo tablets
Number of subjects: 105
Study: 17367893

Group type: EXPERIMENTAL
Intervention: 40-mg controlled-release doxycycline once daily
Number of subjects: 537

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 537
Study: 15481334

Group type: EXPERIMENTAL
Intervention: Ibuprofen (600 mg/6 hr during 3 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ibuprofen-arginate (600 mg/6 hr during 3 days)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ibuprofen-arginate
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ibuprofen and ibuprofen-arginate
Number of subjects: 24
Study: 11560082

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 6 mg.kg‐1
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF)
Number of subjects: 12
Study: 9627589

Group type: EXPERIMENTAL
Intervention: Budesonide 100 micrograms
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Budesonide 200 micrograms
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Budesonide 400 micrograms
Number of subjects: 404

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 404
Study: 8176099

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 3666158

Group type: EXPERIMENTAL
Intervention: Human alpha interferon 3 x 10(6) units subcutaneously daily for 1 year
Number of subjects: 32

Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 32
Study: 31243447

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted BMI
Number of subjects: 228951

Group type: COMPARATOR
Intervention: Genetically predicted breast size
Number of subjects: 228951
Study: 28438377

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum DSM9843 (LP299V)
Number of subjects: 438

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 438
Study: 25559009

Group type: EXPERIMENTAL
Intervention: Almond diet (1.5 oz. of almonds/day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control diet (isocaloric muffin substitution)
Number of subjects: 48
Study: 23208198

Group type: EXPERIMENTAL
Intervention: Adjunctive rotigotine (≤16 mg/24 h)
Number of subjects: 653
Study: 21911107

Group type: COMPARATOR
Intervention: Haloperidol (0.25 to 10 mg)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Risperidone (0.25 to 4 mg)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Olanzapine (1.25 to 20 mg)
Number of subjects: 64
Study: 19186725

Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion treatment
Number of subjects: 0
Study: 16322100

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural alcohol program (CBAP)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Post-mailed minimal intervention (PMMI)
Number of subjects: 177
Study: 15229466

Group type: EXPERIMENTAL
Intervention: Ritonavir (300 mg twice daily for 11 days)
Number of subjects: 12
Study: 12681546

Group type: EXPERIMENTAL
Intervention: Surgical treatment via transsylvian transinsular approach
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 66
Study: 10807818

Group type: EXPERIMENTAL
Intervention: Cocaine-positive group
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Cocaine-positive admitted patients
Number of subjects: 116

Group type: COMPARATOR
Intervention: All patients
Number of subjects: 116
Study: 8819246

Group type: EXPERIMENTAL
Intervention: High-purity factor IX (HP-FIX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prothrombin complex concentrate (PCC)
Number of subjects: 0
Study: 1284093

Group type: EXPERIMENTAL
Intervention: Atracurium (0.5 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pancuronium (0.1 mg/kg)
Number of subjects: 20
Study: 3933262

Group type: EXPERIMENTAL
Intervention: Epidural nicomorphine
Number of subjects: 163

Group type: COMPARATOR
Intervention: Intramuscular opiates
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Epidural group
Number of subjects: 163

Group type: COMPARATOR
Intervention: Intramuscular group
Number of subjects: 163
Study: 30156361

Group type: EXPERIMENTAL
Intervention: Nebulized terbutaline combined with ipratropium bromide (5 mg terbutaline + 0.5 mg IB)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Terbutaline alone (5 mg)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 232
Study: 29843509

Group type: EXPERIMENTAL
Intervention: Aprepitant (80 mg) plus Palonosetron (0.075 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Palonosetron (0.075 mg)
Number of subjects: 100
Study: 26900902

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring
Number of subjects: 2629

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2629

Group type: COMPARATOR
Intervention: Dapivirine vaginal ring and Placebo
Number of subjects: 2629
Study: 24957552

Group type: EXPERIMENTAL
Intervention: Neo-adjuvant hormone therapy
Number of subjects: 481
Study: 23302159

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 92
Study: 21488379

Group type: EXPERIMENTAL
Intervention: Therapy based on level of kidney function activity
Number of subjects: 0
Study: 18580346

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol 1 g
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% NaCl 100 ml (placebo)
Number of subjects: 40
Study: 16078956

Group type: EXPERIMENTAL
Intervention: Postprandial hypotension (PPH)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Postprandial systolic blood pressure (SBP) of 120 mmHg or less
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Low diastolic blood pressure (DBP)
Number of subjects: 179

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 179
Study: 11914297

Group type: EXPERIMENTAL
Intervention: Random effects model OR
Number of subjects: 1843

Group type: EXPERIMENTAL
Intervention: Fixed effects model OR
Number of subjects: 1843

Group type: EXPERIMENTAL
Intervention: Random effects model RR
Number of subjects: 1843

Group type: EXPERIMENTAL
Intervention: Fixed effects RD
Number of subjects: 1843

Group type: EXPERIMENTAL
Intervention: Random effects RD
Number of subjects: 1843
Study: 9918521

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CE) 0.625 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: CE combined with simvastatin
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 28
Study: 7486184

Group type: EXPERIMENTAL
Intervention: Halothane at 0.5 MAC
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Isoflurane at 0.5 MAC
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Desflurane at 0.5 MAC
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Halothane at 1.5 MAC
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Isoflurane at 1.5 MAC
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Desflurane at 1.5 MAC
Number of subjects: 21
Study: 2254502

Group type: EXPERIMENTAL
Intervention: Interpersonal problem-solving skills improvement
Number of subjects: 36
Study: 7380201

Group type: EXPERIMENTAL
Intervention: Cimetidine (300 mg a.c.) added to pancreatic enzyme therapy
Number of subjects: 8

Group type: COMPARATOR
Intervention: Pancreatic enzyme therapy
Number of subjects: 8
Study: 31233843

Group type: EXPERIMENTAL
Intervention: 100 μg Fentanyl Sublingual Tablets (FST)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 5 mg Subcutaneous Morphine (SCM)
Number of subjects: 114
Study: 28064386

Group type: EXPERIMENTAL
Intervention: Brief supportive‐expressive therapy (SET)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Both groups (SET and control)
Number of subjects: 77
Study: 26010143

Group type: EXPERIMENTAL
Intervention: GABA extract (200 mg GABA) with alcohol drinking (GA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo intake and alcohol drinking (PA)
Number of subjects: 0
Study: 24334868

Group type: EXPERIMENTAL
Intervention: Freeze-dried strawberry (FDS) supplementation (2 cups of FDS beverage daily for 6 weeks)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Freeze-dried strawberry (FDS) supplementation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo powder with strawberry flavor
Number of subjects: 36
Study: 21575097

Group type: EXPERIMENTAL
Intervention: Two-component compression (2CC) system
Number of subjects: 30

Group type: COMPARATOR
Intervention: Inelastic multicomponent compression bandages (IMC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups (2CC and IMC)
Number of subjects: 30
Study: 19564767

Group type: EXPERIMENTAL
Intervention: Lateral fluoroscopic guidance (L guidance)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both lateral and AP fluoroscopic guidance (AP + L guidance)
Number of subjects: 20
Study: 17076961

Group type: EXPERIMENTAL
Intervention: Cue exposure treatment
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard cognitive-behavioral treatment
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 63
Study: 15324297

Group type: EXPERIMENTAL
Intervention: Present tense be use in children with SLI
Number of subjects: 22

Group type: COMPARATOR
Intervention: Present tense be use in typically developing children (control group)
Number of subjects: 22
Study: 11528199

Group type: COMPARATOR
Intervention: Desmopressin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Laser acupuncture
Number of subjects: 40
Study: 9754456

Group type: EXPERIMENTAL
Intervention: Profiled Hemodialysis (PHD)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard Hemodialysis (SHD)
Number of subjects: 11
Study: 7850227

Group type: EXPERIMENTAL
Intervention: Noninvasive method for cholesterol extraction from the surface layers of the epidermis
Number of subjects: 105
Study: 3232784

Group type: EXPERIMENTAL
Intervention: Intra-operative crystalloid (1000 ml compound sodium lactate solution)
Number of subjects: 100

Group type: COMPARATOR
Intervention: None (control group)
Number of subjects: 100
Study: 8198262

Group type: COMPARATOR
Intervention: Spinal block with 0.5% hyperbaric bupivacaine, 2.5 mL
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Sequential combined spinal-epidural block with 1.5 mL of 0.5% hyperbaric bupivacaine and additional doses if needed
Number of subjects: 42
Study: 678733

Group type: EXPERIMENTAL
Intervention: Experimental social work service (task‐centered casework)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Control (routine follow‐up service)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Excluded group (not part of the trial)
Number of subjects: 261
Study: 30316627

Group type: EXPERIMENTAL
Intervention: hf‐rTMS
Number of subjects: 26

Group type: COMPARATOR
Intervention: sham hf‐rTMS
Number of subjects: 26
Study: 28857852

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula at 60 L/min
Number of subjects: 12
Study: 25584489

Group type: EXPERIMENTAL
Intervention: Rilotumumab (7.5 and 15 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low exposure to Rilotumumab
Number of subjects: 0
Study: 24315810

Group type: EXPERIMENTAL
Intervention: Participants with MS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (healthy participants)
Number of subjects: 20
Study: 23027910

Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption
Number of subjects: 30433

Group type: EXPERIMENTAL
Intervention: High alcohol consumption
Number of subjects: 30433

Group type: EXPERIMENTAL
Intervention: Binge drinking among moderate drinkers
Number of subjects: 30433

Group type: COMPARATOR
Intervention: Low alcohol consumption
Number of subjects: 30433
Study: 20003306

Group type: EXPERIMENTAL
Intervention: Fruit and Vegetable Index (FVI)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet Index (MDI)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Interaction of FVI with ozone
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Interaction of MDI with ozone
Number of subjects: 158

Group type: COMPARATOR
Intervention: Dietary effect
Number of subjects: 158
Study: 18090435

Group type: EXPERIMENTAL
Intervention: R-flurbiprofen 400 mg/d
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: R-flurbiprofen 800 mg/d
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: R-flurbiprofen 1600 mg/d
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: R-flurbiprofen (all doses)
Number of subjects: 48
Study: 12819938

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ovarian suppression
Number of subjects: 0
Study: 11075969

Group type: EXPERIMENTAL
Intervention: 50 microg misoprostol
Number of subjects: 143

Group type: COMPARATOR
Intervention: 3 mg dinoprostone
Number of subjects: 143
Study: 8837563

Group type: EXPERIMENTAL
Intervention: Intraaortic balloon counterpulsation (IABP) for 48 hours, n = 23
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conservative therapy, n = 22 (control)
Number of subjects: 45
Study: 1331217

Group type: EXPERIMENTAL
Intervention: Repirinast 300 mg twice daily for 7 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Cromolyn 40 mg single dose
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 3913725

Group type: EXPERIMENTAL
Intervention: Fenoprofen calcium
Number of subjects: 100

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 100
Study: 31213447

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine-70% isopropanol
Number of subjects: 4100

Group type: COMPARATOR
Intervention: 5% povidone iodine-69% ethanol
Number of subjects: 4100
Study: 28974833

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 150
Study: 25782770

Group type: EXPERIMENTAL
Intervention: Endurance training combined with cognitive remediation (30min, 3 times/wk for endurance training; 30min, 2 times/wk for CACR training starting from week 6)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Endurance training combined with cognitive remediation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Table soccer with cognitive remediation (same CACR training as endurance group)
Number of subjects: 22
Study: 23616624

Group type: EXPERIMENTAL
Intervention: Bortezomib consolidation therapy (20 doses over 21 weeks)
Number of subjects: 370

Group type: COMPARATOR
Intervention: No consolidation (control group)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Bortezomib consolidation therapy
Number of subjects: 370
Study: 20673648

Group type: EXPERIMENTAL
Intervention: Verum remedies (Nux Vomica or Coffea Cruda, 30c doses)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo pellets
Number of subjects: 54